eLife is a unique collaboration between funders and practitioners of research to communicate influential discoveries in the life and biomedical sciences in the most effective way. It is launched with support from the Howard Hughes Medical Institute, the Wellcome Trust, and the Max Planck Society in November 2012. eLife represents a new model of scientific publishing, designed to meet the needs of scientists in life sciences and biomedicine in a better way. This includes free, immediate, online access to scientific articles; rapid, fair, and constructive review; and innovation in content presentation – in short, a journal for scientists, run by scientists. Initial decisions are made by eLife’s senior editors, and, if a submission is selected for further assessment, full peer review is overseen by eLife’s 175-member board of reviewing editors. The reviewing editor and reviewers consult once peer review comments are submitted, and provide a consolidated list of instructions to authors – eliminating unnecessary and time-consuming rounds of revision.
Since Yale researchers first observed the ability of the anesthetic ketamine to dramatically improve symptoms in many patients with treatment-resistant depression more than two decades ago, the drug has provided a powerful ...
Apr 17, 2024
0
11
A study led by University of Queensland researchers has identified the main types of E. coli bacteria that cause neonatal meningitis, and revealed why some infections recur despite being treated with antibiotics.
Apr 16, 2024
0
19
Researchers have used computational models to understand what drives the accumulation of alpha-synuclein protein, a key culprit in the development of Parkinson's disease.
Apr 2, 2024
0
37
An analysis of how brains with different forms of autism develop has revealed common underlying mechanisms that may respond to existing medications.
Mar 27, 2024
0
31
A global collaborative research group comprising 131 researchers from 105 laboratories across seven countries has published a paper in eLife. The study identifies brain energy metabolism dysfunction leading to altered pH ...
Mar 26, 2024
0
157
When you stub your toe or bump your head, you know that rubbing the injury can lessen the ouch. But how? New research from the lab of Scott B. Hansen, Ph.D., shows how physical pressure on cells can reduce pain signals, while ...
Feb 27, 2024
0
74
In collaboration with their colleagues at the Donders Institute, researchers at the Netherlands Institute for Neuroscience have developed a simulator that enables artificial visual observations for research into visual prostheses. ...
Feb 27, 2024
0
35
People with aphantasia lack visual imagination. Researchers from the University Hospital Bonn (UKB), the University of Bonn and the German Center for Neurodegenerative Diseases (DZNE) investigated how the lack of mental imagery ...
Feb 27, 2024
1
1
Imagine if we could inhale scents that delay the onset of cancer, inflammation, or neurodegenerative disease. Researchers at the University of California, Riverside, are poised to bring this futuristic technology closer to ...
Feb 27, 2024
0
0
Just over a year ago, the European Union and the US Food and Drug Administration approved a new anti-retroviral drug to treat human immunodeficiency virus (HIV) infections. Lenacapavir is the first drug available to patients ...
Feb 13, 2024
0
8
